MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Autonomic Dysfunction in Parkinson’s Disease: Role of New Surrogate Markers

S. Menon R, A. Lutterotti (Ernakulam, India)

Meeting: 2018 International Congress

Abstract Number: 1562

Keywords: Autonomic dysfunction, Autonomic nervous system, Parkinsonism

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: The physiology of respiration is modulated by autonomic efferent neurons and circulating hormones. A continuous ambulatory monitoring of various respiratory parameters helps in early identification of sympatho-vagal(autonomic) dysregulation in Parkinson’s Disease(PD).

Background: We aim to compare different respiratory parameters in normal individuals and PD subjects & to detect autonomic dysregulation in PD subjects.

Methods: Prospective cross sectional study which included 40 subjects- 20 normal subjects and 20 diagnosed PD subjects (H& Y Stage <3) were conducted at the Departments of Neurosciences,Academic Medisch Centrum,Amsterdam,Netherlands & Sarada Hospital,Kochi,India.A 24hr ambulatory monitoring of each subject was done during the sleep-wake cycle &phases of activities using the respiratory inductance plethysmography.Respiratory parameters like Respiratory Rate Variability(RRV),Thoracoabdominal ratio(TAR%),& Low frequency-high frequency ratio(LF/HF) were assessed.

Results: Mean RRV during sleep in normal & PD subjects were 36.34% & 21.51% respectively.The study showed PD subjects showed lower respiratory rate variability than normal during sleep-wake cycle(p=0.01 & 0.02 respectively).Mean TAR% during sleep in normal and PD groups were 54.18% & 60.86% respectively. During awake state, PD subjects had significantly higher TAR% than normal(p=0.02).LF/HF ratios were highest in PD subjects compared to normal individuals throughout sleep-awake cycle & physical activities.(p=<0.001).

Conclusions: Our study showed the importance of using RRV,TAR%,LF/HF ratio as new surrogate markers for autonomic imbalance & sympath-vagal dysregulation and to detect early dysautonomia in PD subjects.

To cite this abstract in AMA style:

S. Menon R, A. Lutterotti. Autonomic Dysfunction in Parkinson’s Disease: Role of New Surrogate Markers [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/autonomic-dysfunction-in-parkinsons-disease-role-of-new-surrogate-markers/. Accessed July 2, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/autonomic-dysfunction-in-parkinsons-disease-role-of-new-surrogate-markers/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley